Cargando…
Correction to: Complexation with C(60) Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419633/ https://www.ncbi.nlm.nih.gov/pubmed/30868449 http://dx.doi.org/10.1186/s11671-019-2917-y |
| _version_ | 1783403984065658880 |
|---|---|
| author | Grebinyk, Anna Prylutska, Svitlana Grebinyk, Sergii Prylutskyy, Yuriy Ritter, Uwe Matyshevska, Olga Dandekar, Thomas Frohme, Marcus |
| author_facet | Grebinyk, Anna Prylutska, Svitlana Grebinyk, Sergii Prylutskyy, Yuriy Ritter, Uwe Matyshevska, Olga Dandekar, Thomas Frohme, Marcus |
| author_sort | Grebinyk, Anna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6419633 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64196332019-04-05 Correction to: Complexation with C(60) Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro Grebinyk, Anna Prylutska, Svitlana Grebinyk, Sergii Prylutskyy, Yuriy Ritter, Uwe Matyshevska, Olga Dandekar, Thomas Frohme, Marcus Nanoscale Res Lett Correction Springer US 2019-03-13 /pmc/articles/PMC6419633/ /pubmed/30868449 http://dx.doi.org/10.1186/s11671-019-2917-y Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Correction Grebinyk, Anna Prylutska, Svitlana Grebinyk, Sergii Prylutskyy, Yuriy Ritter, Uwe Matyshevska, Olga Dandekar, Thomas Frohme, Marcus Correction to: Complexation with C(60) Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro |
| title | Correction to: Complexation with C(60) Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro |
| title_full | Correction to: Complexation with C(60) Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro |
| title_fullStr | Correction to: Complexation with C(60) Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro |
| title_full_unstemmed | Correction to: Complexation with C(60) Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro |
| title_short | Correction to: Complexation with C(60) Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro |
| title_sort | correction to: complexation with c(60) fullerene increases doxorubicin efficiency against leukemic cells in vitro |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419633/ https://www.ncbi.nlm.nih.gov/pubmed/30868449 http://dx.doi.org/10.1186/s11671-019-2917-y |
| work_keys_str_mv | AT grebinykanna correctiontocomplexationwithc60fullereneincreasesdoxorubicinefficiencyagainstleukemiccellsinvitro AT prylutskasvitlana correctiontocomplexationwithc60fullereneincreasesdoxorubicinefficiencyagainstleukemiccellsinvitro AT grebinyksergii correctiontocomplexationwithc60fullereneincreasesdoxorubicinefficiencyagainstleukemiccellsinvitro AT prylutskyyyuriy correctiontocomplexationwithc60fullereneincreasesdoxorubicinefficiencyagainstleukemiccellsinvitro AT ritteruwe correctiontocomplexationwithc60fullereneincreasesdoxorubicinefficiencyagainstleukemiccellsinvitro AT matyshevskaolga correctiontocomplexationwithc60fullereneincreasesdoxorubicinefficiencyagainstleukemiccellsinvitro AT dandekarthomas correctiontocomplexationwithc60fullereneincreasesdoxorubicinefficiencyagainstleukemiccellsinvitro AT frohmemarcus correctiontocomplexationwithc60fullereneincreasesdoxorubicinefficiencyagainstleukemiccellsinvitro |